Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8081703rdf:typepubmed:Citationlld:pubmed
pubmed-article:8081703lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:8081703lifeskim:mentionsumls-concept:C1444754lld:lifeskim
pubmed-article:8081703lifeskim:mentionsumls-concept:C1705914lld:lifeskim
pubmed-article:8081703lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:8081703pubmed:issue1-2lld:pubmed
pubmed-article:8081703pubmed:dateCreated1994-10-11lld:pubmed
pubmed-article:8081703pubmed:abstractTextWe investigated the relationship between telomere length and various characteristics of tumor cells in 46 lung cancer specimens (40 primary lesions and six metastatic lesions). Three variant patterns of telomere length were observed in 16 cases (34.8%): reduction in 13 cases, elongation in two cases, and convergence in one case. These variant patterns were frequently observed in small cell carcinomas, in metastatic lesions, and in cases which possessed the S-type allele of the L-myc gene. All three cases with telomere elongation or convergence were associated with a poor prognosis. This is compatible with the previous report suggesting that telomerase activity may be an indicator of immortality in vitro. In adenocarcinoma, telomere reduction or elongation was also observed in the early stages with a low percentage of cells in the S-phase, while in cases with other histologic types, these changes were observed only in late stage, in metastatic lesions, or in cancerous tissues with a high percentage of cells in the S-phase. Although the reduction of telomere length in these tissues may be a result of many cell divisions, it may represent another stage of carcinogenesis in early-stage adenocarcinoma.lld:pubmed
pubmed-article:8081703pubmed:languageenglld:pubmed
pubmed-article:8081703pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8081703pubmed:citationSubsetIMlld:pubmed
pubmed-article:8081703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8081703pubmed:statusMEDLINElld:pubmed
pubmed-article:8081703pubmed:monthJullld:pubmed
pubmed-article:8081703pubmed:issn0169-5002lld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:YoshidaYYlld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:HasegawaKKlld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:HiyamaKKlld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:IshiokaSSlld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:AwayaYYlld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:InaiKKlld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:YoneharaSSlld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:InyakuKKlld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:ShirotaniYYlld:pubmed
pubmed-article:8081703pubmed:authorpubmed-author:HiyamaEElld:pubmed
pubmed-article:8081703pubmed:issnTypePrintlld:pubmed
pubmed-article:8081703pubmed:volume11lld:pubmed
pubmed-article:8081703pubmed:geneSymbolc-myclld:pubmed
pubmed-article:8081703pubmed:geneSymbolN-myclld:pubmed
pubmed-article:8081703pubmed:geneSymbolL-myclld:pubmed
pubmed-article:8081703pubmed:ownerNLMlld:pubmed
pubmed-article:8081703pubmed:authorsCompleteNlld:pubmed
pubmed-article:8081703pubmed:pagination29-41lld:pubmed
pubmed-article:8081703pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:meshHeadingpubmed-meshheading:8081703-...lld:pubmed
pubmed-article:8081703pubmed:year1994lld:pubmed
pubmed-article:8081703pubmed:articleTitleAlteration in length of telomeric repeats in lung cancer.lld:pubmed
pubmed-article:8081703pubmed:affiliationSecond Department of Internal Medicine, Hiroshima University School of Medicine, Japan.lld:pubmed
pubmed-article:8081703pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8081703pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed